N. DANIŞ Et Al. , "Paritaprevir ritonavir ombitasvir dasabuvir (PrOD) treatment of kidney transplant recipients with hepatitis C infection," APASL , 2018
DANIŞ, N. Et Al. 2018. Paritaprevir ritonavir ombitasvir dasabuvir (PrOD) treatment of kidney transplant recipients with hepatitis C infection. APASL .
DANIŞ, N., TÖZ, H., ÜNAL, N. G., YILMAZ, M., TURAN, İ., GÜNŞAR, F., ... KARASU, A. Z.(2018). Paritaprevir ritonavir ombitasvir dasabuvir (PrOD) treatment of kidney transplant recipients with hepatitis C infection . APASL
DANIŞ, NİLAY Et Al. "Paritaprevir ritonavir ombitasvir dasabuvir (PrOD) treatment of kidney transplant recipients with hepatitis C infection," APASL, 2018
DANIŞ, NİLAY Et Al. "Paritaprevir ritonavir ombitasvir dasabuvir (PrOD) treatment of kidney transplant recipients with hepatitis C infection." APASL , 2018
DANIŞ, N. Et Al. (2018) . "Paritaprevir ritonavir ombitasvir dasabuvir (PrOD) treatment of kidney transplant recipients with hepatitis C infection." APASL .
@conferencepaper{conferencepaper, author={NİLAY DANIŞ Et Al. }, title={Paritaprevir ritonavir ombitasvir dasabuvir (PrOD) treatment of kidney transplant recipients with hepatitis C infection}, congress name={APASL}, city={}, country={}, year={2018}}